|Bid||1.2400 x 0|
|Ask||1.2450 x 0|
|Day's range||1.2350 - 1.2500|
|52-week range||0.8700 - 1.6620|
|Beta (3Y monthly)||0.18|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.44|
The Starpharma Ltd (ASX: SPL) share price jumped in early trade after the company provided an update on its phase 1/2 clinical colorectal cancer drug trial.
The Bravura Solutions Ltd (ASX:BVS) share price and the Bubs Australia Ltd (ASX:BUB) share price are two of four charging higher on Thursday. Here's why...
In 2006 Jackie Fairley was appointed CEO of Starpharma Holdings Limited (ASX:SPL). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...
A look at the shareholders of Starpharma Holdings Limited (ASX:SPL) can tell us which group is most powerful. Institutions often own shares in more established companies, while it’s not unusual Read More...